1 |
TUBB3
| [10] Phagosome Phagosome, Gap junction, Alzheimer disease, Parkinson disease, Amyotrophic lateral sclerosis, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
2 |
TUBB4A
| [10] Phagosome Phagosome, Gap junction, Alzheimer disease, Parkinson disease, Amyotrophic lateral sclerosis, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
3 |
TUBB4B
| [10] Phagosome Phagosome, Gap junction, Alzheimer disease, Parkinson disease, Amyotrophic lateral sclerosis, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
4 |
ADRA1D
| [6] Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | D00255
D00255
|
Carvedilol
| [4] 57 57, 86, 113, 210 |
5 |
ADRA1B
| [6] Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | D00255
D00255
|
Carvedilol
| [4] 57 57, 86, 113, 210 |
6 |
ADRA1A
| [7] Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | D00255
D00255
|
Carvedilol
| [4] 57 57, 86, 113, 210 |
7 |
ADRB1
| [11] Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy | D00255
D00255
|
Carvedilol
| [4] 57 57, 86, 113, 210 |
8 |
ADRB2
| [9] Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation | D00255
D00255
|
Carvedilol
| [4] 57 57, 86, 113, 210 |
9 |
ACE
| [6] Renin-angiotensin system Renin-angiotensin system, Renin secretion, Chagas disease, Coronavirus disease - COVID-19, Hypertrophic cardiomyopathy, Diabetic cardiomyopathy | D07892
D07892
|
Enalapril
| [6] 19 19, 46, 66, 113, 210, 222 |
10 |
EDNRA
| [7] Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer | D01227
D01227
|
Bosentan
| [10] 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
11 |
EDNRA
| [7] Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer | D07077
D07077
|
Ambrisentan
| [7] 51 51, 84, 85, 86, 88, 210, 211 |
12 |
EDNRA
| [7] Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer | D07538
D07538
|
Bosentan
| [10] 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
13 |
EDNRA
| [7] Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer | D10135
D10135
|
Macitentan
| [5] 51 51, 85, 86, 88, 210 |
14 |
EDNRB
| [6] Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Relaxin signaling pathway, Pathways in cancer | D01227
D01227
|
Bosentan
| [10] 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
15 |
EDNRB
| [6] Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Relaxin signaling pathway, Pathways in cancer | D07538
D07538
|
Bosentan
| [10] 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
16 |
EDNRB
| [6] Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Relaxin signaling pathway, Pathways in cancer | D10135
D10135
|
Macitentan
| [5] 51 51, 85, 86, 88, 210 |
17 |
TUBB
| [10] Phagosome Phagosome, Gap junction, Alzheimer disease, Parkinson disease, Amyotrophic lateral sclerosis, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
18 |
F10
| [1] Complement and coagulation cascades Complement and coagulation cascades | D07086
D07086
|
Rivaroxaban
| [1] 210 210 |
19 |
TUBB8
| [10] Phagosome Phagosome, Gap junction, Alzheimer disease, Parkinson disease, Amyotrophic lateral sclerosis, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
20 |
TUBB2B
| [10] Phagosome Phagosome, Gap junction, Alzheimer disease, Parkinson disease, Amyotrophic lateral sclerosis, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
21 |
NR3C2
| [1] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption | D00443
D00443
|
Spironolactone
| [3] 210 210, 218, 225 |
22 |
NR3C2
| [1] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption | D01115
D01115
|
Eplerenone
| [2] 210 210, 215 |
23 |
ATP1A1
| [18] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Insulin secretion, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Endocrine and other factor-regulated calcium reabsorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Carbohydrate digestion and absorption, Protein digestion and absorption, Bile secretion, Mineral absorption | D00298
D00298
|
Digoxin
| [3] 8 8, 46, 210 |
24 |
ATP1A2
| [18] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Insulin secretion, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Endocrine and other factor-regulated calcium reabsorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Carbohydrate digestion and absorption, Protein digestion and absorption, Bile secretion, Mineral absorption | D00298
D00298
|
Digoxin
| [3] 8 8, 46, 210 |
25 |
ATP1A3
| [18] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Insulin secretion, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Endocrine and other factor-regulated calcium reabsorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Carbohydrate digestion and absorption, Protein digestion and absorption, Bile secretion, Mineral absorption | D00298
D00298
|
Digoxin
| [3] 8 8, 46, 210 |
26 |
ATP1A4
| [18] cGMP-PKG signaling pathway cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Insulin secretion, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Endocrine and other factor-regulated calcium reabsorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Carbohydrate digestion and absorption, Protein digestion and absorption, Bile secretion, Mineral absorption | D00298
D00298
|
Digoxin
| [3] 8 8, 46, 210 |
27 |
AVPR1A
| [4] Calcium signaling pathway Calcium signaling pathway, Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction | D00101
D00101
|
Vasopressin
| [1] 210 210 |
28 |
AVPR1B
| [4] Calcium signaling pathway Calcium signaling pathway, Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction | D00101
D00101
|
Vasopressin
| [1] 210 210 |
29 |
AVPR2
| [3] Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vasopressin-regulated water reabsorption | D00101
D00101
|
Vasopressin
| [1] 210 210 |
30 |
PTGIR
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Platelet activation | D06213
D06213
|
Treprostinil
| [6] 51 51, 84, 85, 86, 88, 210 |
31 |
PTGS1
| [5] Arachidonic acid metabolism Arachidonic acid metabolism, Metabolic pathways, Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes | D00109
D00109
|
Acetylsalicylic acid
| [14] 13 13, 22, 46, 49, 51, 58, 64, 86, 97, 113, 158, 210, 231, 251 |
32 |
PTGS2
| [22] Arachidonic acid metabolism Arachidonic acid metabolism, Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, C-type lectin receptor signaling pathway, IL-17 signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Alzheimer disease, Pathways of neurodegeneration - multiple diseases, Leishmaniasis, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Pathways in cancer, Chemical carcinogenesis - DNA adducts, MicroRNAs in cancer, Small cell lung cancer | D00109
D00109
|
Acetylsalicylic acid
| [14] 13 13, 22, 46, 49, 51, 58, 64, 86, 97, 113, 158, 210, 231, 251 |
33 |
THRA
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway | D08128
D08128
|
Liothyronine
| [4] 13 13, 78, 210, 212 |
34 |
THRB
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway | D08128
D08128
|
Liothyronine
| [4] 13 13, 78, 210, 212 |
35 |
TUBB2A
| [10] Phagosome Phagosome, Gap junction, Alzheimer disease, Parkinson disease, Amyotrophic lateral sclerosis, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
36 |
TUBB1
| [10] Phagosome Phagosome, Gap junction, Alzheimer disease, Parkinson disease, Amyotrophic lateral sclerosis, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
37 |
TUBB6
| [10] Phagosome Phagosome, Gap junction, Alzheimer disease, Parkinson disease, Amyotrophic lateral sclerosis, Huntington disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
38 |
PDE5A
| [3] Purine metabolism Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway | D02008
D02008
|
Tadalafil
| [7] 6 6, 51, 75, 84, 86, 113, 210 |
39 |
PDE5A
| [3] Purine metabolism Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway | D08514
D08514
|
Sildenafil
| [17] 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 |
40 |
PDE5A
| [3] Purine metabolism Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway | D10027
D10027
|
Udenafil
| [2] 86 86, 210 |